Abbott Laboratories stock edges lower as Team Abbott spotlights runner's Boston Marathon story

Traders Union
All News
Companies
Abbott Laboratories slips 0.54% today

Highlights

ABT remains under sustained selling pressure, consistently trading below key short-, medium-, and long-term moving averages.
Momentum indicators confirm a pronounced bearish trend, with multiple signals indicating the stock is deeply oversold.
Price is likely to consolidate between $97.75 and $101.75, with a heightened risk of breaching new yearly lows if support breaks.

Downward trends persist as major averages and Ichimoku cap upside

ABT is trading at $99.76, well below the MA-20 ($104.64), MA-50 ($108.92), and MA-200 ($123.50), which confirms persistent downward pressure across short-, medium-, and long-term trends. The Ichimoku Kijun on D1 is at $106.04, acting as immediate resistance. Near-term support sits at MA-20 ($104.64), with key support further down at MA-50 ($108.92), while the Ichimoku Kijun ($106.04) and MA-100 ($116.38) form near-term and key resistance, respectively.

Bearish momentum intensifies as price hits lower weekly extreme

Momentum indicators show pronounced bearishness, with MACD on D1 at -2.98 ("Strong Sell") and ADX at 29.04 ("Sell") indicating a well-established downward trend. RSI (31.38), Stoch RSI (26.35), and CCI (-113.72) on D1 all signal oversold conditions, while BBP is negative and "Oversold," suggesting sellers dominate intraday flows. Weekly movement reflects this pressure, as ABT is trading at $99.76, down from a previous weekly close of $100.30, a 0.58% decline. The price is positioned at the very bottom of the weekly range, with volatility at 4.52%. This tone aligns with strong weekly selling, as confirmed by momentum indicators and the lack of convincing upward attempts.

Downside favored as low breakout risks limit near-term recovery

For the coming week, ABT is expected to move between $97.75 and $101.75, which keeps price action just above the 52-week low ($99.35) and far from the 52-week high ($139.06). The probability of a price increase is very low (less than 20%), while a further decline is much more likely, as all W1 indicators—MA-50, RSI, ADX, and MACD—point to "Sell" or "Strong Sell" signals. The baseline scenario envisions consolidation in this narrow range near recent lows. A bullish scenario would require a close above near-term resistance ($104.64–$106.04), but momentum and trend indicators suggest this is unlikely in the near term. Conversely, a bearish scenario could see a breakdown below the $97.75 support, exposing the price to fresh yearly lows.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Abbott Laboratories was experiencing sustained bearish momentum and persistent downside pressure according to technical indicators. As the current market environment continues to evolve, investors should monitor for any reversal signals or a break of notable support levels to gauge the next directional move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.